Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Late Hematologic Recovery after CPX-351 Induction Chemotherapy in AML: Predictive Disease and Patient's Factors and Their Impact on Survival

Blood (2023) 142 (Supplement 1): 4275.

https://doi.org/10.1182/blood-2023-182993

Published: 2023

Journal Articles

In Search of Drivers of CD34+/CD38-/CD26+ Leukemia Stem Cells Persistence in CML Patients

Paola Pacelli, Elena Bestoso, Anna Sicuranza, Elisabetta Abruzzese, Luigiana Luciano, Alessandra Iurlo, Marzia Defina, Sara Fredducci, Monica Crugnola, Valentina Giai, Federica Sorà, Sara Galimberti, Donatella Raspadori, Monica Bocchia

Blood (2022) 140 (Supplement 1): 12171–12172.

https://doi.org/10.1182/blood-2022-169085

Published: 2022

Journal Articles

Minimal Residual Disease (MRD) at 10 -6 Measured By Next Generation Flow (NGF) during Daratumumab Consolidation Therapy: Analysis at 18 Months Follow up of DART4MM Study (Daratumumab Treatment For Multiple Myeloma Eradication )

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-141538

Published: 2020

Journal Articles

Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS)

Blood (2020) 136 (Supplement 1): 45–46.

https://doi.org/10.1182/blood-2020-139306

Published: 2020

Journal Articles

Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation

Monica Bocchia, Anna Sicuranza, PhD, Paola Pacelli, PhD, Patrizia Pregno, Mario Annunziata, Federica Sorà, MD, Elisabetta Abruzzese, MD, Monica Crugnola, MD, Luigiana Luciano, MD, Alessandra Iurlo, MD, Sara Galimberti, MD PhD, Anna Marina Liberati, Ilaria Ferrigno, PhD, Sara Ciofini, Marzia Defina, Luca Puccetti, Donatella Raspadori, PhD

Blood (2019) 134 (Supplement_1): 2919.

https://doi.org/10.1182/blood-2019-122814

Published: 2019

Journal Articles

Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Level. Comparison of Qpcr, d-PCR and CD26 Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR)

Elisabetta Abruzzese, MD, Monica Bocchia, MD PhD, Simona Bernardi, PhD, Malgorzata Monika Trawinska, MD, Donatella Raspadori, PhD, Camilla Zanaglio, PhD, Francesco Bondanini, MD, Anna Sicuranza, PhD, Paola Pacelli, PhD, Michele Malagola, MD, Paolo de Fabritiis, MD

Blood (2018) 132 (Supplement 1): 4244.

https://doi.org/10.1182/blood-2018-99-120363

Published: 2018

Journal Articles

Persistence of Residual Circulating CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients in Treatment Free Remission

Blood (2017) 130 (Supplement 1): 249.

https://doi.org/10.1182/blood.V130.Suppl_1.249.249

Published: 2017

Journal Articles

Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia

Vanessa Zurli, Giuliana Wimmer, Francesca Cattaneo, Veronica Candi, Emanuele Cencini, Alessandro Gozzetti, Donatella Raspadori, Giuseppe Campoccia, Francesca Sanseviero, Monica Bocchia, Cosima Tatiana Baldari, Anna Kabanova

Blood (2017) 130 (18): 2006–2017.

https://doi.org/10.1182/blood-2017-03-775858

Published: 2017

Includes: Supplemental data

Journal Articles

Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy

Blood (2016) 128 (22): 942.

https://doi.org/10.1182/blood.V128.22.942.942

Published: 2016

Journal Articles

Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status?

Lara Aprile, Luca Puccetti, Sara Galimberti, Antonella Gozzini, Francesca Scarpini, Marzia Defina, Federica De Majo, Claudia Baratè, Anna Sicuranza, Veronica Candi, Barbara Scappini, Donatella Raspadori, Alessandro Gozzetti, Alberto Bosi, Mario Petrini, Monica Bocchia

Blood (2013) 122 (21): 1482.

https://doi.org/10.1182/blood.V122.21.1482.1482

Published: 2013

Journal Articles

Usefulness of Unicel DxH 800 Cell Population Data in the Detection of Plasmacell Leukemia: 2 Cases Report

Donatella Raspadori, BS, Santina Sirianni, BS, Alessandro Gozzetti, MD PhD, Francesco Lauria, MD, Claudio Fogli, Nicola Di Gaetano, BS

Blood (2011) 118 (21): 4915.

https://doi.org/10.1182/blood.V118.21.4915.4915

Published: 2011

Journal Articles

Molecular Cytogenetics Analysis of 13q14 Biallelic Deletion in Chronic Lymphocytic Leukemia: A Study on 250 Patients

Alessandro Gozzetti, MD PhD, Giulia Papini, MD, Rosaria Crupi, BS, Adele Frasconi, BS, Francesco Forconi, Emanuele Cencini, MD, Donatella Raspadori, BS, Francesco Lauria, MD

Blood (2011) 118 (21): 1454.

https://doi.org/10.1182/blood.V118.21.1454.1454

Published: 2011

Journal Articles

Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia

Nagaja Capitani, Orso Maria Lucherini, Elisa Sozzi, Micol Ferro, Nico Giommoni, Francesca Finetti, Giulia De Falco, Emanuele Cencini, Donatella Raspadori, Pier Giuseppe Pelicci, Francesco Lauria, Francesco Forconi, Cosima T. Baldari

Blood (2010) 115 (18): 3726–3736.

https://doi.org/10.1182/blood-2009-08-239244

Published: 2010

Includes: Supplemental data

Journal Articles

Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior

Blood (2009) 114 (21): 4696–4702.

https://doi.org/10.1182/blood-2009-03-212449

Published: 2009

Includes: Supplemental data

Journal Articles

CMLVAX100 Peptide Vaccinations induce Peptide Specific “cytotoxic” CD4+ T Cells (CD4+CTLs) in Chronic Myeloid Leukemia Patients: New Insights about Peptide Vaccine-Mediated Antitumor Response

Monica Bocchia, Maristella Tassi, Micaela Ippoliti, Marzia Defina, Elisabetta Abruzzese, Malgorzata Monika Trawinska, Alessandro Gozzetti, Donatella Raspadori, Francesco Lauria

Blood (2008) 112 (11): 3209.

https://doi.org/10.1182/blood.V112.11.3209.3209

Published: 2008

Journal Articles

Equivalent Efficacy and Lower Toxicity of Subcutaneous Cladribine at Reduced Doses (Five versus Seven Consecutive days) in Hairy Cell Leukemia: An Interim Analysis of the ICGHCL 2004 Protocol by the Italian Cooperative Group on Hcl

Blood (2008) 112 (11): 3174.

https://doi.org/10.1182/blood.V112.11.3174.3174

Published: 2008

Journal Articles

Characterization of CD4 + T Cell Response Induced by p210-Derived Peptide Vaccinations in CML Patients.

Monica Bocchia, MD, Micaela Ippoliti, P.h.D, Elisabetta Abruzzese, M.D., Maristella Tassi, P.h.D, Marzia Defina, M.D., Malgorzata M. Trawinska, M.D., Alessandro Gozzetti, M.D., Donatella Raspadori, P.h.D, Francesco Lauria, M.D.

Blood (2007) 110 (11): 1808.

https://doi.org/10.1182/blood.V110.11.1808.1808

Published: 2007

Journal Articles

LAT Down-Regulation in T Lymphocytes from B-Cell Chronic Lymphocytic Leukemia: A Possible Mechanism for T Cell Incompetence.

Maristella Tassi, BS, Donatella Raspadori, BS, Mariapia Lenoci, MD, Francesco Forconi, MD, Maria Antonietta Dell’Aversano, LT, Ida Chitarrelli, MD, Francesco Lauria, MD

Blood (2006) 108 (11): 3882.

https://doi.org/10.1182/blood.V108.11.3882.3882

Published: 2006

Journal Articles

Hairy Cell Leukemias (HCL) with Unmutated V-Genes Have a Poorer Response to Single Agent 2CdA Than HCL with Mutated V-Genes.

Francesco Forconi, MD, DM, PhD, Elisa Sozzi, BSci, Donatella Raspadori, BSci, Francesca Toraldo, MD, Marzia Defina, MD, Francesco Zaja, MD, Luigi Rigacci, MD, Caterina Stelitano, MD, Andrea Gallamini, MD, Piero Galieni, MD, Tamara Intermesoli, MD, P.M. Stefani, MD, Alfonso Zaccaria, MD, Mariapia Lenoci, MD, Monica Bocchia, MD, Francesco Lauria, MD

Blood (2006) 108 (11): 2327.

https://doi.org/10.1182/blood.V108.11.2327.2327

Published: 2006

Journal Articles

ZAP-70 Expression in T Cells of B-Cell Chronic Lymphocytic Leukaemia: Correlation with Negative Prognostic Factors of the Disease.

Donatella Raspadori, BS, Maristella Tassi, BS, Mariapia Lenoci, MD, Deborah Bravi, BS, Maria Antonietta Dell’Aversano, LT, Francesco Forconi, MD, Francesco Lauria, MD

Blood (2005) 106 (11): 4998.

https://doi.org/10.1182/blood.V106.11.4998.4998

Published: 2005

NARROW

Late Hematologic Recovery after CPX-351 Induction Chemotherapy in AML: Predictive Disease and Patient's Factors and Their Impact on Survival

In Search of Drivers of CD34+/CD38-/CD26+ Leukemia Stem Cells Persistence in CML Patients

Minimal Residual Disease (MRD) at 10 -6 Measured By Next Generation Flow (NGF) during Daratumumab Consolidation Therapy: Analysis at 18 Months Follow up of DART4MM Study (Daratumumab Treatment For Multiple Myeloma Eradication )

Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS)

Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation

Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Level. Comparison of Qpcr, d-PCR and CD26 Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR)

Persistence of Residual Circulating CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients in Treatment Free Remission

Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia

Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy

Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status?

Usefulness of Unicel DxH 800 Cell Population Data in the Detection of Plasmacell Leukemia: 2 Cases Report

Molecular Cytogenetics Analysis of 13q14 Biallelic Deletion in Chronic Lymphocytic Leukemia: A Study on 250 Patients

Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia

Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior

CMLVAX100 Peptide Vaccinations induce Peptide Specific “cytotoxic” CD4+ T Cells (CD4+CTLs) in Chronic Myeloid Leukemia Patients: New Insights about Peptide Vaccine-Mediated Antitumor Response

Equivalent Efficacy and Lower Toxicity of Subcutaneous Cladribine at Reduced Doses (Five versus Seven Consecutive days) in Hairy Cell Leukemia: An Interim Analysis of the ICGHCL 2004 Protocol by the Italian Cooperative Group on Hcl

Characterization of CD4 + T Cell Response Induced by p210-Derived Peptide Vaccinations in CML Patients.

LAT Down-Regulation in T Lymphocytes from B-Cell Chronic Lymphocytic Leukemia: A Possible Mechanism for T Cell Incompetence.

Hairy Cell Leukemias (HCL) with Unmutated V-Genes Have a Poorer Response to Single Agent 2CdA Than HCL with Mutated V-Genes.

ZAP-70 Expression in T Cells of B-Cell Chronic Lymphocytic Leukaemia: Correlation with Negative Prognostic Factors of the Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only